Search

Royalty Pharma PLC (Class A)

Lezárt

SzektorEgészségügy

67.3 -0.27

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

66.73

Maximum

68.08

Fő mutatók

By Trading Economics

Bevétel

-589M

-295M

Értékesítés

44M

674M

P/E

Szektor átlag

35.383

51.78

Egy részvényre jutó nyereség

1.32

Osztalékhozam

1.35

Profit margin

-43.713

Munkavállalók

100

EBITDA

-387M

176M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+5% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

1.35%

1.96%

Következő osztalékfizetési dátum

2026. dec. 10.

Következő korábbi osztalék dátum

2026. nov. 13.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

5.5B

38B

Előző nyitás

67.57

Előző zárás

67.3

Royalty Pharma PLC (Class A) Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. nov. 6. 22:51 UTC

Royalty Pharma PLC shares advanced in after-hours trading, reaching a peak return amid strong performance and significantly above their 20-day moving average.

2026. nov. 5. 21:08 UTC

Royalty Pharma PLC traded near unchanged, retracing from a notable high reached earlier in the session, while remaining above its 20-day moving average.

2026. nov. 4. 21:04 UTC

Correlated Moves
News

Royalty Pharma PLC raised its full-year 2026 guidance for portfolio receipts to $3.50B-$3.55B after reporting strong Q3 results with $890M in receipts.

2026. nov. 3. 21:07 UTC

Royalty Pharma PLC shares are declining, pulling back from an earlier gain but remaining above the 20-day moving average and near the upper end of its one-month range.

2026. okt. 30. 20:03 UTC

Royalty Pharma PLC shares are advancing, significantly above their 20-day moving average and near the upper end of their one-month range.

2026. okt. 29. 20:07 UTC

Correlated Moves

Royalty Pharma PLC shares are higher, supported by strong momentum in the broader market and gains in key holdings within the XLV ETF during earnings season.

2026. okt. 28. 20:07 UTC

Royalty Pharma PLC shares are declining, following a broader market trend lower since Tuesday, despite stabilizing somewhat after an earlier drop.

2026. okt. 27. 20:01 UTC

Royalty Pharma PLC is trading modestly higher, supported by a notable increase in market volume and remaining significantly above its 20-day moving average.

2026. okt. 26. 22:16 UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, continuing its performance from Monday's close and remaining well above its 20-day moving average.

2026. okt. 23. 20:07 UTC

Shares of Royalty Pharma PLC are advancing, showing a slight gain since Thursday's close and recovering to near its highest point during Friday's trading session.

2026. okt. 22. 20:02 UTC

Royalty Pharma PLC is gaining amid a broader market downturn, diverging from the recent upward momentum observed in prior sessions.

2026. okt. 21. 20:41 UTC

Royalty Pharma PLC is experiencing a notable decline in after-market trading, moving lower since Wednesday's close and trading at the lower end of today's range.

2026. okt. 20. 22:46 UTC

Royalty Pharma PLC's shares advanced in after-market hours on Tuesday, remaining just above the previous close and 7.13% above its 20-day moving average.

2026. okt. 19. 20:07 UTC

Royalty Pharma PLC shares are declining, hitting a midday low after an early peak.

2026. okt. 16. 20:02 UTC

News

Royalty Pharma PLC declared a quarterly dividend of $0.235 per Class A share, payable on December 10, 2026, to shareholders of record as of November 13, 2026.

2026. okt. 15. 20:07 UTC

Correlated Moves

Royalty Pharma PLC shares advanced, supported by broader market strength, while the Health Care Select Sector SPDR ETF reached a record high.

2026. okt. 14. 20:02 UTC

Royalty Pharma PLC is advancing during Wednesday's market hours, continuing its upward trajectory since Tuesday's close with unusually high trading volume.

2026. okt. 13. 20:02 UTC

Royalty Pharma PLC shares fell sharply, trading near the low end of their one-month range after an initial rebound earlier in the session.

2026. okt. 12. 20:06 UTC

Royalty Pharma PLC is advancing, reflecting a strong performance since Friday's close, with today's price peaking in the early afternoon before settling slightly lower.

2026. okt. 9. 21:01 UTC

Royalty Pharma PLC shares traded lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026. okt. 8. 20:13 UTC

Royalty Pharma PLC shares advanced modestly during after-market hours on Thursday, holding steady with no notable fluctuations since the market closed.

2026. okt. 7. 19:35 UTC

News

Royalty Pharma PLC shares advanced modestly after Morgan Stanley raised its price target to $67.00 from $65.00 while maintaining an Overweight rating.

2026. okt. 6. 20:12 UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, maintaining a steady position below its 20-day moving average and near the lower end of its one-month range.

2026. okt. 5. 20:02 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend amid broader pharmaceutical sector weakness and reflecting unusually high market volume.

2026. okt. 2. 20:07 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend and hitting a session low just before market close, significantly below its 20-day moving average.

2026. okt. 1. 20:07 UTC

Royalty Pharma PLC shares fell sharply, remaining below their 20-day moving average and positioned near the lower end of their one-month range.

2026. szept. 30. 20:20 UTC

Royalty Pharma PLC gained in after-market trading, recovering from a slight loss and marking a significant shift near the lower end of its one-month trading range.

2026. szept. 29. 20:07 UTC

Royalty Pharma PLC shares fell modestly, continuing a decline from Monday's close, amid a broader market dip and positioning below the 20-day moving average.

2026. szept. 28. 22:06 UTC

Royalty Pharma PLC traded modestly higher in after-market hours, maintaining a stable performance despite being below its 20-day moving average.

2026. szept. 24. 19:25 UTC

Royalty Pharma PLC shares are rising, reflecting notable market strength, although they remain below the 20-day moving average and near the one-month range's lower end.

Társak összehasonlítása

Árváltozás

Royalty Pharma PLC (Class A) Előrejelzés

Célár

By TipRanks

5% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 70.667 USD  5%

Magas 78 USD

Alacsony 63 USD

6 Wall Street elemző 12 hónapos célárain alapulva a(z)Royalty Pharma PLC (Class A) termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

6 ratings

6

Vétel

0

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Royalty Pharma PLC (Class A)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
help-icon Live chat